ASI launches range of multi-asset separately managed accounts

MyPortfolio range unveiled

Emanuela Hawker
clock • 1 min read

Aberdeen Standard Investments' (ASI) is launching a new multi-asset solution, MyPortfolio, consisting of three separately managed accounts which will be exclusively available on Standard Life's Wrap and Elevate platforms.

MyPortfolio consists of 15 multi-asset portfolios split into three ranges and five risk levels that offer a choice of solutions aligned to attitude to risk.

The portfolios offer exposure to a range of different asset classes and will be rebalanced on an ongoing basis to maintain target risk levels.

The group said the separately managed accounts (SMAs) structure can benefit from strategically optimised asset allocation, with its MyPortfolio being managed by the multi-manager strategies team that is currently in charge of around £27bn of assets.

Aberdeen Standard Investments appoints ESG investment director

The Index SMA consists primarily of ASI's traditional index tracker funds, while the Index Plus SMA provides additional exposure to ASI-enhanced index funds as well as some carefully selected active funds. Meanwhile, the Select SMA has the capability to invest in a broader array of investment styles and third-party managers.

James Millard, ASI's co-head of multi-manager strategies, commented: "This is a straightforward, flexible separately managed account service that offers broad diversification and full transparency. The choice of investment styles, price points and risk levels makes it suitable for a wide range of investors."

ASI promotes McKillop to lead client solutions group

ASI's head of UK propositions, David Tiller, added: "With the continuing demands of regulation, we want to deliver investment solutions to advisers that will meet their clients' needs in a transparent and cost-effective way while offering them choice in how they do this.

"We are delighted ASI has extended its award winning multi-asset solutions capability into the SMA market, helping advisers segment their client base while reducing regulatory risk."

More on Investment

Daniel Koller (pictured) is head portfolio manager at BB Biotech.

Daniel Koller: Three decades of biotech evolution

US still offering the most biotech names

Daniel Koller
clock 08 January 2024 • 4 min read
Stories of the Week: New Year Honours; Fundsmith slips down ii list; Another short position against Hargreaves Lansdown

Stories of the Week: New Year Honours; Fundsmith slips down ii list; Another short position against Hargreaves Lansdown

The biggest stories from the world of investment and asset management this week: New Year Honours; Fundsmith; Hargreaves Lansdown

Sarka Halas
clock 05 January 2024 • 1 min read
Partner Insight: Outlook 2024 from Royal London Asset Management

Partner Insight: Outlook 2024 from Royal London Asset Management

Royal London Asset Management
clock 03 January 2024 • 1 min read
Trustpilot